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Background: FAD synthase is known to catalyze the biosynthesis of FAD in cytosol and mitochondria.
Results: The existence of a nuclear FAD synthase and a FAD-hydrolyzing activity is demonstrated.
Conclusion: A dynamic pool of FAD exists in the nucleus.
Significance:Nuclear, mitochondrial, and cytosolic FAD synthase pools constitute a flavin network involved in the regulation
of cellular metabolism and epigenetic events.
FAD is a redox cofactor ensuring the activity ofmany flavoen-
zymes mainly located in mitochondria but also relevant for
nuclear redox activities. The last enzyme in the metabolic path-
way producing FAD is FAD synthase (EC 2.7.7.2), a protein
known to be localized both in cytosol and inmitochondria. FAD
degradation to riboflavin occurs via still poorly characterized
enzymes, possibly belonging to theNUDIX hydrolase family. By
confocal microscopy and immunoblotting experiments, we
demonstrate here the existence of FAD synthase in the nucleus
of different experimental rat models. HPLC experiments dem-
onstrated that isolated rat liver nuclei contain 300 pmol of
FADmg1 protein, which was mainly protein-bound FAD. A
mean FAD synthesis rate of 18.1 pmolmin1mg1 protein was
estimated by both HPLC and continuous coupled enzymatic
spectrophotometric assays. Rat liver nuclei were also shown to
be endowed with a FAD pyrophosphatase that hydrolyzes FAD
with an optimum at alkaline pH and is significantly inhibited by
adenylate-containing nucleotides. The coordinate activity of
these FAD forming and degrading enzymes provides a potential
mechanismbywhich a dynamic pool of flavin cofactor is created
in the nucleus. These data, which significantly add to the bio-
chemical comprehension of flavin metabolism and its subcellu-
lar compartmentation, may also provide the basis for a more
detailed comprehension of the role of flavin homeostasis in bio-
logically and clinically relevant epigenetic events.
Riboflavin (Rf, vitamin B2)5 is the precursor of FMN and
FAD, two cofactors that ensure the functionality of many
enzymes, namely flavoenzymes, involved in fundamental bio-
chemical processes, such as the oxidative metabolism of carbo-
hydrates, amino acids, and fatty acids and the mitochondrial
electron transport (1–3). A number of other regulatory pro-
cesses crucial for cell life and death, among which are ROS
production, antioxidant defense, protein folding, and chroma-
tin remodeling, also depend on more than 100 different flavo-
proteins, 75% of which use FAD as cofactor. Although in the
large majority of cases flavoenzymes are oxidoreductases, they
can also catalyze non-redox reactions (i.e., transfer, synthesis,
isomerization, and ligations) (for reviews see Refs. 4–7). Con-
sistently, FAD-dependent enzyme deficiency and/or impair-
ment of flavin homeostasis in humans and experimental ani-
mals have been linked to several diseases, such as cancer,
cardiovascular diseases, anemia, abnormal fetal development,
and neuromuscular and neurological disorders (for reviews see
Ref. 8 and references therein).
Although bacteria, protists, fungi, plants, and some animals
can synthesize Rf, mammals must obtain this water-soluble
vitamin from food and, to a lesser extent, from intestinalmicro-
flora. Cells can take up Rf via specific translocators, three of
which have been recently characterized in humans (9–12).
Once in the cell, Rf is converted into the flavin cofactor FAD via
the sequential action of riboflavin kinase (ATP:riboflavin 5
phosphotransferase, EC 2.7.1.26), which transfers a phosphoryl
group from ATP to Rf to form FMN, and FAD synthase, previ-
ously known as FAD synthetase (FADS; ATP:FMN adenylyl-
transferase, EC 2.7.7.2), the enzyme responsible for FMN
adenylation to FAD. In mammals, riboflavin kinase and FADS
are two distinct monofunctional enzymes that have been puri-
fied from rat tissues and biochemically characterized (13–15).
A controversial matter in FADS biochemistry is its subcellu-
lar localization. For many years it has been assumed that in
eukaryotes FAD biosynthesis occurred only in the cytosol (13,
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14, 16, 17). However, using cell fractionation procedures and
enzymatic activity measurements, we have demonstrated the
presence of FADS activity in mitochondria from rat liver (18,
19), Saccharomyces cerevisiae (20, 21) and Nicotiana tabacum
Yellow Bright-2 (22). More recently, the existence of different
natural FADS isoforms with distinct features regarding molec-
ular mass and subcellular localization has been confirmed by
biochemical and immunohistochemical approaches (23).
Our hypothesis was that different FADS isoforms with com-
partment-specific functions may exist in eukaryote stems from
the cloning and functional characterization of two products of
the human FADS gene (FLAD1), namely transcript variants 1
(hFADS1) and 2 (hFADS2) (24, 25). The two corresponding
protein products were shown to differ for an extra sequence of
97 amino acids at the N terminus (present only in hFADS1)
containing a putative mitochondrial targeting peptide, as pre-
dicted by bioinformatics. Accordingly, a subsequent paper con-
clusively demonstrated that, in humans, hFADS1 is mitochon-
drial, whereas hFADS2 is cytosolic (23).
Recently, two additional splicing variants for the FLAD1 gene
have been deposited in the NCBI Entrez Gene database (gene
identifier 80308), namely transcript variants 3 and 4, whose
simultaneous presence with hFADS1 has been observed at
the transcriptional level in the intestinalHT-29 cell line (8). The
specific tissue distribution and subcellular localization of these
isoforms are still uncharacterized and enigmatic. The possibil-
ity of other subcellular localizations, different from cytosol and
mitochondria, has not been excluded by the available studies. In
fact, in two recent papers, a plasma membrane localization in
neuronal cells (26) and a nuclear localization, presumably asso-
ciated to the nuclear flavoprotein lysine-specific demethylases
in adipocytes (27), have been suggested for FADS.
In this paper, by confocal microscopy and immunoblotting
approaches, we show for the first time the nuclear localization
of FADS in different experimental rat models. The existence of
FAD synthesizing and hydrolyzing activities involved in main-
taining FAD homeostasis in isolated rat liver nuclei is also
demonstrated.
EXPERIMENTAL PROCEDURES
Materials—All chemicals were of analytical or highest avail-
able grade and, unless otherwise stated, were obtained from
Sigma-Aldrich. PVDF Hybond-P was from Amersham Biosci-
ences GE Healthcare. The dye reagent for protein assay was
fromBio-Rad. Anti-OxPhos Complex II 70-kDa subunitmouse
monoclonal antibody (anti-succinate dehydrogenase) and
Alexa Fluor-conjugated anti-rabbit or anti-mouse IgG second-
ary antibodies were from Molecular Probes, Inc. Mouse anti-
Hsp60 monoclonal antibody was from Stressgen. Monoclonal
mouse anti--actin and anti-lamin A/C antibodies were from
Abcam. Mouse anti-tubulin monoclonal antibody was from
Sigma-Aldrich. Peroxidase-conjugated anti-rabbit and anti-
mouse IgG secondary antibodies were from Thermo Scientific.
Solvents and salts used for HPLC were from J. T. Baker.
Cell Culture—BHK-21 cells were purchased fromATCC and
cultured as described in Refs. 28 and 29. INS-1E cells, a clonal
-cell line derived from rat insulinoma (a generous gift from
Prof. C. Wollheim, University of Gene`ve), were grown in com-
plete medium as described in Ref. 28. Cardiac myocytes and
fibroblasts were prepared from ventricles of neonatal Wistar
rats (0–2 days after birth) essentially as in Refs. 30 and 31.
Astrocytes were prepared from primary cell cultures of neocor-
tical tissues as described inRef. 32. The cells weremaintained in
a humidified incubator at 37 °C in the presence of 5% CO2 until
used.
Cell Lysate Preparation—Confluent cells seeded on plastic
6-well plates were washed twice with ice-cold PBS and har-
vested with lysis buffer (150 mM NaCl, 5 mM EDTA, 5 mM
EGTA, 50 mM HEPES, 1% Triton X-100, 10 mM -mercapto-
ethanol, 0.1 mM PMSF, 2 g/ml aprotinin/leupeptin/pepsta-
tin). Lysates were frozen at20 °C for at least 2 h and thereafter
thawed and centrifuged at 16,000 g for 15 min. Pellet (Triton
X-100-insoluble proteins) and supernatant (Triton X-100-sol-
uble proteins) fractions were resuspended in loading buffer (50
mM Tris-HCl, 2% SDS, 10% glycerol, 100 mM DTT).
Cell Fractionation—Subcellular fractionation of neonatal rat
cardiac fibroblasts was performed essentially as described in
Ref. 33. Briefly, confluent 150-mm dishes were washed twice
with ice-cold PBS and thereafter lysed with 2ml of Buffer A (10
mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA,
1 mM DTT, 0.5 mM PMSF, 2 g/ml Aprotinin/Leupeptin/Pep-
statin). The cell homogenate was then passed six times through
a 30-gauge needle and centrifuged at 700  g for 10 min to
obtain the crude nuclear fraction. The crude nuclear pellet was
resuspended in 200 l of Buffer C (20 mM HEPES, pH 7.9, 0.4
mM KCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT) and left for 30
min on a rotating wheel. Soluble nuclear proteins were then
separated fromDNA and debris by centrifugation at 16,000 g
for 30 min. Cytosolic proteins were obtained by centrifugating
the first cell homogenate supernatant at 21,000 g for 2 h. The
two subcellular protein fractions were finally resuspended in
loading buffer (see above) and subjected to immunoblotting.
Preparation of Pure Nuclei from Rat Liver—Nuclei were iso-
lated from the liver of maleWistar rats by differential centrifu-
gation in sucrose gradient essentially as in Ref. 34. Briefly, rat
liver was homogenized in ice-coldmediumA (0.25 M sucrose, 3
mM CaCl2, 1 mM PMSF) through a Potter-Elvehjem homoge-
nizer and centrifuged at 700 g for 6min at 4 °C. The pellet was
then resuspended and manually homogenized in ice-cold
medium B (0.34 M sucrose, 3 mM CaCl2, 1 mM PMSF) in a 1:4
ratio and centrifuged at 700 g for 10min at 4 °C. The obtained
pellet was resuspended and manually homogenized in ice-cold
medium B in a 1:3 ratio, and an equal volume of mediumAwas
gently stratified under it. After centrifuging at 1500  g for 15
min at 4 °C, the crude nuclei pellet was resuspended and man-
ually homogenized in ice-cold medium C (2.2 M sucrose, 3 mM
CaCl2, 1 mM PMSF) in a 1:3 ratio and then ultracentrifuged at
45,000  g for 1 h at 4 °C. The white pellet containing the iso-
lated nuclei, on the bottom of the tube, was finally resuspended
in ice-cold Tris-Cl buffer (20 mM Tris-Cl, pH 7.5, 0.5 mM
PMSF). Where indicated, isolated nuclei were solubilized by
treatment with the non-ionic detergent Triton X-100 (0.1%)
and subjected to immunoblotting or ultrafiltered by centrifugal
filters (Microcon YM-10, Millipore) and utilized for the HPLC
and enzymatic assays.
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Immunoblotting—SDS-PAGE separated proteins were elec-
trotransferred onto a PVDF membrane using a transblot semi-
dry electrophoretic transfer cell (Sigma-Aldrich). The immobi-
lized proteins were incubated overnight with a 3000-fold
dilution of a polyclonal antiserum against hFADS, as in Ref. 23.
Other antibodies were used to reveal and quantify protein
markers, including a mouse monoclonal anti--actin antibody
(1:10,000 dilution), a mouse monoclonal anti-tubulin antibody
(1:2,000 dilution), a mouse monoclonal anti-lamin A/C anti-
body (1:500 dilution), a mouse monoclonal anti-succinate
dehydrogenase antibody (1:2,000 dilution), and a rabbit poly-
clonal anti-rat dimethylglycine dehydrogenase antibody
(1:1,000 dilution). The bound antibodies were visualized with
the aid of secondary anti-rabbit or anti-mouse IgG antibodies
conjugated with peroxidase (1:3,500 dilution). Quantitative
evaluation of immunoreactive protein bands was carried by
densitometric analysis using the ImageQuant 5.2 software
(Molecular Dynamics).
Cell Immunofluorescence and Confocal Microscopy—Immu-
nofluorescence experiments were performed essentially as
described in Ref. 35. Briefly, cells seeded on glass coverslips at
the desired confluencewere fixedwith 3.7%paraformaldehyde/
PBS for 20min andwashed three timeswith PBS.After permea-
bilization with 0.1% Triton X-100 and blocking with 0.1% gela-
tin in PBS, the cells were incubated with the specific anti-FADS
antiserum raised in rabbit (23) (1:300 dilution) or coincubated
with a monoclonal anti-Hsp60 antibody (1:100 dilution) over-
night at 4 °C. Coverslips were then washed three times with
0.1% gelatin in PBS and incubated at room temperature for 1 h
with Alexa Fluor 488 or 568 secondary antibodies (1:1000 dilu-
tion). After onewashwithPBS, nucleiwere counterstainedwith
Hoechst 33658 (2M). The coverslips were finally washed three
times with ice-cold PBS, rapidly rinsed in distilled water, and
thenmounted onmicroscope slideswithMowiol 4-88mount-
ing medium. Confocal images were captured with a Leica TCS
SP5 confocal microscope (Leica Microsystems, Mannheim,
Germany) using 40 (N.A.  1.25) or 63 (N.A.  1.32) oil
immersion objectives, a 100-milliwatt argon laser (488 and 543
nm lines) and a 50-milliwatt diode (405 nm) as in Ref. 36. Con-
focal images were analyzed using the software Image J (37).
Quantitation of Flavins—Rf, FMN, and FAD content was
measured in neutralized perchloric extracts bymeans of HPLC,
essentially as described in Refs. 18–20, 22, and 38. Separation
was achieved by means of a Gilson HPLC system including a
model 306 pump and a model 307 pump equipped with a
FP-2020 Plus Jasco fluorescence detector and a Unipoint sys-
tem software.Quantitative determination of Rf, FMN, and FAD
was carried out using a calibration curve made in each experi-
ment by using standard solutions diluted in the extraction
solution.
Measurements of FAD Synthesis Rate—Detergent-solubi-
lized or ultrafiltered nuclei (0.1–0.2 mg) were preincubated at
37 °C in 100 l of a medium consisting of 50 mM Tris-HCl (pH
7.5), 10 M FMN, and 5mMATP; where indicated, either 5 mM
MgCl2 or 1 mM EDTA was added. At the appropriate time, the
reaction was stopped either by treatment with perchloric acid
followed by neutralization or by boiling at 100 °C for 3 min
followed by centrifugation at 14,000 g for 4min at 4 °C. In the
former case, Rf, FMN, and FAD content was analyzed using
HPLC (see above). In the latter case, newly synthesized FAD
was measured spectrophotometrically by using the FAD-de-
tecting system, as described in Refs. 18 and 20. Briefly, the
amount of synthesized FAD was determined by revealing the
reconstituted holo-D-amino acid oxidase activity derived from
FAD binding to the apo-D-amino acid oxidase, using 25 mM
D-alanine as substrate. NADH oxidation in the L-lactate dehy-
drogenase (LDH)-coupled reaction was followed spectropho-
tometrically at 340 nm, and the rate was calculated by mea-
suring the slope of the tangent to the initial part of the
experimental curve. This rate was proven to be proportional to
FAD concentration. Calibration curves were obtained by using
standard FAD solutions, and corrections were also made to
account for the inhibition caused by FMN and ATP added to
the reconstitution assay.
Measurements of FAD Hydrolysis Rate—Metabolism of
externally added FAD was monitored in detergent solubilized
rat liver nuclei by means of fluorimetric and HPLC measure-
ments, essentially as in Refs. 38 and 39. In the case of fluorimet-
ric measurements, flavin derivative emission spectra (excita-
tion wavelength at 450 nm) and time drive measurements
(excitation and emission wavelengths at 450 and 520 nm,
respectively) were carried out at 37 °C in 50 mM Tris-HCl (pH
7.5), 5 mM MgCl2 by means of a LS50B PerkinElmer Life Sci-
ences spectrofluorimeter. Flavin fluorescence emission spectra
were corrected as in Ref. 40 by adding a few crystals of sodium
dithionite to the nuclei suspension. When FAD hydrolysis was
measured, the endogenous flavin fluorescence was not consid-
ered because it was found to be negligible when compared with
that externally added to the subcellular suspension. In each
experiment, FAD, FMN, and Rf fluorescence values were cali-
brated using standard flavin solutions. Their concentrations
were spectrophotometrically calculated by using the 450 values
of 12.2 mM1cm1 for FMN and Rf, and 11.3 mM1cm1 for
FAD. Under the experimental conditions used here, the FAD
fluorescence constant (KFAD)was proven to be10 times lower
than those of FMN and Rf (KFMN/Rf), which did not differ sig-
nificantly from each other (19, 41). Thus, the rate of FAD
hydrolysis, i.e., the rate of FMN  Rf formation, expressed as
nmol of FAD hydrolyzedmin1mg1 protein and calculated
from the rate of fluorescence intensity increase, was measured
as the slope of the tangent to the initial part of the experimental
curve by applying the following equation,
o  FK Vf	tm (Eq. 1)
where F is expressed in fluorescence arbitrary units, Vf is
expressed inml,KKFMN/RfKFAD is expressed asM1,t
is expressed in min, andm is the mass of proteins in mg.
HPLC measurements were carried out on neutralized per-
chloric extracts of aliquots of the subcellular suspension (100
l) taken at various times (see above). The kinetic parameters
were calculated with the Grafit software (version 3.00; Eritha-
cus Software), as in Refs. 22 and 38.
Other Assays—Protein concentration was assayed according
to Bradford (42), using bovine serum albumin as standard. Lac-
tate dehydrogenase (EC 1.1.1.27) activity was spectrophoto-
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metrically measured at 25 °C in 50 mM Tris-Cl (pH 7.5) by fol-
lowing the decrease in absorbance at 340 nm caused by NADH
oxidation (340 6.2 mM1 cm1). The reaction was started
by adding rat homogenate or isolated nuclei (0.05–0.1 mg of
protein) to the reaction mixture containing 1 mM pyruvate, 2.5
mg/ml rotenone, and 0.1 mM NADH, essentially as in Ref. 43.
Nicotinamide-mononucleotide adenylyltransferase activity
(EC 2.7.7.1) was continuously revealed by means of a spectro-
fluorimetric enzymatic analysis carried out essentially as in Ref.
44. Rat homogenate or isolated nuclei (0.6 mg of protein each)
were added to 50 mM Tris-HCl (pH 7.6) supplemented with 20
mMMgCl2 in the presence of the NAD detecting system con-
sisting of 0.35% ethanol, 5 IU alcohol dehydrogenase (EC
1.1.1.1), and 35 mM semicarbazide. The reaction was started by
adding 1 mM nicotinamide mononucleotide and 5 mM ATP.
Under the experimental conditions described here, newly syn-
thesized NAD was immediately reduced to NADH. The rate
of NADH appearance, which reflects the rate of NAD synthe-
sis, was fluorimetrically measured by means of a LS50B
PerkinElmer Life Sciences spectrofluorimeter, with excitation
and emission wavelengths set at 340 and 456 nm, respectively.
The rate of fluorescence increase was obtained by measuring
the slope of the tangent to the initial part of the experimental
curve and expressed as nmol of NAD synthesizedmin1
mg1 protein. In each experiment, the rate of NAD synthesis
in the homogenates and nuclear samples was calibrated by add-
ing a standard solution of NAD to the NAD detecting
system.
RESULTS
Evidence for a Nuclear FADS—During a previous work (23)
aimed at assessing the subcellular localization of the human
isoforms hFADS1 and hFADS2, confocal microscopy analysis
performed on BHK-21 cells subjected to overexpression exper-
iments revealed an unexpected nuclear localization of the nat-
ural protein inmost of the nontransfected cells (see Fig. 6 inRef.
23). This observation was next confirmed by immunofluores-
cence experiments performed on the same cell line in control
conditions (Fig. 1, A–C). Colocalization analysis performed
with National Institutes of Health ImageJ software clearly
showed a nuclear localization of FADS (white pixels in the
merged images depicted in Fig. 1C). In parallel, to gain insight
into the apparent molecular mass of the natural isoforms of
FADS cross-reacting with the anti-FADS antiserum produced
in our laboratory (23), immunoblotting analyses were carried
out on BHK-21 cell lysates (Fig. 1D) obtained in the presence of
Triton X-100 (1%).
In these experimental conditions, a major band migrating at
65 kDa accompanied by a 55-kDa immunoreactive band was
evident, whereas other less abundant protein bands could also
be observed. As visible from the representative blot reported in
Fig. 1D, these bands were observed both in the soluble (super-
natant) and insoluble (pellet, presumably DNA-containing)
fractions of cell lysates. Notwithstanding the apparent enrich-
ment of the 65-kDa band in theTritonX-100-insoluble pellet, if
comparedwith the-actin band (more than 75% released in the
soluble fraction), the majority of FADS bands was shown to be
released in the supernatant (5 ng/100 mg of protein), whereas
its total amount in the pellet was less than 10%. Whether the
different immunoreactive bands correspond to post-transla-
tionallymodified forms or to different isoforms of the enzyme is
currently unknown. FADS subcellular localization was next
explored by confocal fluorescence microscopy on primary cul-
tures of neonatal rat ventricular cardiomyocytes, a cell type in
which the oxidativemetabolism is expected to crucially depend
on flavin cofactor supply (Fig. 2).
After fixation, permeabilization, and incubation with the
anti-FADS-specific antiserum, the immunocomplexes were
visualized with a secondary antibody conjugated with Alexa
Fluor 568 (Fig. 2A). Mitochondria were marked by using a
monoclonal antibody against the mitochondrial chaperonin
Hsp60 followed by a secondary antibody conjugated with Alexa
Fluor 488 (Fig. 2B). After nuclei counterstaining with Hoechst
33568 (Fig. 2C), the coverslips were analyzed by confocal fluo-
rescence microscopy. Colocalization analysis clearly showed
both amitochondrial and a nuclear localization of FADS (white
pixels in the merged images depicted in Fig. 2, D and E). The
nuclear localization of FADSwas further confirmed by confocal
microscopy experiments performed on primary cultures of rat
astrocytes (Fig. 3A) and insulin secreting INS1-E  cells (Fig.
3B), amodel known for being particularly rich in FAD cofactors
(45).
FIGURE 1. Fluorescence microscopy and immunoblotting evidence of
FADS localization in BHK-21 cell nuclei. A, fixed and permeabilized BHK-21
cells were incubated with the polyclonal anti-FADS antiserum followed by
incubation with an Alexa Fluor 488-conjugated anti-mouse antibody (green).
B, nuclei were stained with Hoechst 33658 (blue, B). C, colocalization of FADS
with the nuclear marker is depicted in white. Scale bar, 50 m. D, immuno-
blotting of different anti-FADS-immunoreactive bands in BHK-21 cells.
BHK-21 cells were lysed using 1% Triton X-100 as described under “Experi-
mental Procedures.” Both the Triton X-100-soluble (TX sol) and Triton X-100-
insoluble (TX ins) fractions were analyzed by immunoblotting with the anti-
FADSantiserum.His6-hFADS2 (0.03g)was also loaded (hFADS2, first lane) as
a control. The same PVDF membrane was tested with the anti--actin anti-
body. The arrows indicate the position of the main anti-FADS-immunoreac-
tive bands.
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Also in these cell models, the distribution ratio of FADS
between the pellet (insoluble fraction) and the supernatant (sol-
uble fraction), as analyzed by immunoblotting, confirmed an
enrichment of -FADS cross-reactive bands (at 65 and 55 kDa)
in the pellet (data not shown). During our survey of different rat
cell models aimed at assessing the subcellular localization of
FADS, a marked nuclear localization was observed in primary
cultures of neonatal rat ventricular fibroblasts (Fig. 4, A–C).
Given the strong nuclear signal and the possibility of obtaining
more material at a lower cost in respect to cardiac myocytes, we
elected to perform a subcellular fractionation on this cell model.
After the simplified subfractionation procedure described under
FIGURE2.Confocal evidenceofmitochondrial andnuclear localizationofFADS inprimary culturesofneonatal rat ventricular cardiomyocytes.A, fixed
and permeabilized neonatal rat cardiomyocytes were incubated with the polyclonal anti-FADS antiserum followed by incubation with an Alexa Fluor 568-
conjugatedanti-rabbit antibody (red).B,mitochondriawere revealedwith themonoclonal anti-Hsp60antibodyandanAlexaFluor 488-conjugatedanti-mouse
antibody (green). C, nuclei were counterstainedwith Hoechst 33658 (blue).D and E, the colocalization of FADSwithmitochondria (D) and nuclei (E) is depicted
inwhite. Scale bar, 50 m.
FIGURE 3. Confocal evidence of a nuclear FADS localization in rat primary culture and cell lines. Fixed and permeabilized rat neonatal astrocytes (row A)
and insulin secreting INS-1E -cells (row B) were incubated with the polyclonal anti-FADS antiserum followed by incubation with an Alexa Fluor 568-conju-
gated anti-rabbit antibody (red). Nuclei were stainedwithHoechst 33658 (blue). In the last panel of each row, the colocalization between FADS and the nuclear
marker is depicted inwhite. Scale bar, 50 m.
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“Experimental Procedures,” the cytosolic and the nuclear frac-
tions were analyzed by immunoblotting.
Loading equal amounts of each fraction, again different anti-
FADS cross-reactive bandswere revealed (Fig. 4D). Themigrat-
ing range was found to be 65–55 kDa in both the fractions. The
absence ofmitochondrial contamination in the nuclear fraction
was assessed by following the distribution of the specificmarker
enzyme (succinate dehydrogenase flavoprotein subunit). Only
a minimal cytosolic protein contamination was observed by
using tubulin as cytosolic marker (Fig. 4D).
Pure Nuclei Isolated from Rat Liver Show a FAD Synthesizing
Activity—To investigate the putative physiological function of
the nuclear localization of FADS and thus detect its enzymatic
activity, we performed an alternative subcellular fractionation
method starting from the abundant source represented by the
rat liver, a tissue expected to require high levels of FAD because
of its central role in metabolism. Thus, functionally active
nuclei were isolated using a procedure based on differential
centrifugation of liver homogenates in sucrose gradient (see
“Experimental Procedures” for further details). The purity and
functionality of the nuclear fractionswere checked by following
(i) the increase in the enzymatic activity of the nuclear enzyme
nicotinamide-mononucleotide adenylyltransferase, a central
player in the biosynthesis of NAD (46), and (ii) the decrease of
the enzymatic activity of LDH, amarker enzymeof the cytosolic
compartment (Fig. 5A). Immunoblotting experiments per-
formed in parallel confirmed the purity of the nuclear fractions
as indicated by the presence of lamin A/C (a nuclear marker),
the lack of tubulin (a cytosolic marker), and the loss of dimeth-
ylglycine dehydrogenase (a mitochondrial marker) (Fig. 5B).
Loading equal amounts (30 g) of each fraction, different
anti-FADS cross-reactive bands were found (Fig. 5B), with a
clear enrichment of the 65-kDa migrating band in the nuclear
fraction. An increase in the intensity of lower migrating immu-
noreactive bands (range 65–56 kDa) was also appreciable.
Another faint band was visualized at 38 kDa, both in the
homogenate and in the nuclear fractions. The specificity of all
these bands was assessed by immunoinhibition assay (data not
shown) carried out using the recombinant His6-hFADS2 as a
competitor, essentially as in Ref. 23. Remarkably, the 38-kDa
band was not detectable when the overall purification proce-
dure was performed in the absence of CaCl2, suggesting that it
could be an hydrolysis product induced by calcium activated
proteases.
In the aim to further estimate the functional role of FADS in
intact nuclei, we next explored nuclear FAD synthesis by both
HPLC analyses and enzymatic assays. Thus, as first step, we
revealed nuclear acid-extractable flavins by HPLC (Fig. 6A). In
experiments performed with different preparations, the
mean content levels of FAD, FMN, and Rf (that linearly
depended on the protein amount; not shown) were 276
 25,
128 
 31, and 71 
 9 pmolmg1 protein, respectively. To
understand whether the endogenous FAD pools found in the
nuclear extracts were free or protein-bound, nuclei were ultra-
filtered prior to perchloric acid extraction and HPLC analysis
(data not shown). This procedure clearly revealed that themain
acid-extractable nuclear flavins, i.e., FAD (65% of total fla-
vins), is almost completely nonultrafilterable and thus presum-
ably bound to apo-proteins. The less abundant pool of FAD
precursors/hydrolysis products, i.e., FMN and Rf (26 and 9% of
total flavins, respectively), were easy filterable (data not shown).
Next, we performed an enzymatic assay by incubating iso-
lated pure nuclei with the FADS substrate pair (2 M FMN and
5 mM ATP) at 37 °C for up to 10 min. A clear time-dependent
increase of FAD concentration was observed (Fig. 6A), directly
confirming the existence of a nuclear FADS activity. The initial
FIGURE 4. Confocal microscopy and immunoblotting evidence of FADS
localization in thenucleus of neonatal rat ventricular fibroblasts.A, fixed
and permeabilized neonatal rat ventricular fibroblasts were incubated with
the polyclonal anti-FADS antiserum followed by incubation with an Alexa
Fluor 568-conjugated anti-rabbit antibody (red). B, nuclei were stained with
Hoechst 33658 (blue). C, the colocalizion of FADS with Hoechst is depicted in
white. Scale bar, 50 m. Subcellular fractions of cardiac fibroblasts were
obtained as described under “Experimental Procedures.” D, The cytosolic
(Cyt) and nuclear (Ncl) fractions were analyzed by immunoblotting with the
anti-FADS antiserum. After stripping, the same PVDF membrane was tested
with anti-tubulin and anti-succinate dehydrogenase antibodies (anti-SDH),
used as cytosolic and mitochondrial markers, respectively. The arrows indi-
cate the position of the main anti-FADS-immunoreactive bands.
FIGURE 5. Nuclear localization of FADS in rat liver. Pure nuclei (pNcl) were
isolated from rat liver homogenate (Homo) as described under “Experimental
Procedures.”A, distribution of the enzymatic activities of the cytosolicmarker
LDH and the nuclear marker nicotinamide-mononucleotide adenylyltrans-
ferase (NMNAT) between homogenate and nuclei. B, immunoblotting of rat
liver homogenate and pure nuclei (0.03 mg protein each). The same PVDF
membrane tested with the anti-FADS antiserum was tested with anti-tu-
bulin, anti-lamin A/C, and anti-dimethylglycine dehydrogenase (DMGDH)
antibodies.
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rate for FAD synthesis, as measured in these experimental con-
ditions, was of 12.4 pmolmin1mg1 protein. Importantly, a
strong inhibitory effect of HgCl2 (50 M) on natural FADS
activity was demonstrated, as previously observed in experi-
ments performed with the recombinant protein (47) and in
agreement with the high number of cysteines present in the
putative isoforms of rat enzyme (see below).
To further confirm FAD synthesis by isolated nuclei, a cou-
pled enzymatic assay was performed. Thus, the ability of newly
synthesized FAD to continuously reactivate the apo-enzyme of
D-amino acid oxidase and hence to induce D-alanine oxidation
was measured spectrophotometrically at 340 nm as the rate of
NADH oxidation in the LDH-coupled reaction (Fig. 6B). No
FAD synthesis was measurable in the cuvette containing the
ultrafiltered nuclear fraction in the absence of substrates (dot-
ted line). The rate of absorbance decrease (0.008 Amin1)
measured under these experimental conditions was, in fact,
equal to the intercept on the y axis of the calibration curve (data
not shown), i.e., to the residual holo-D-amino acid oxidase pres-
ent in the apo-protein preparation. Also, no FAD was detecta-
ble when the substrates were added in the absence of MgCl2
(MgCl2), in line with the existence of no free (but only
protein-bound) FAD in the ultrafiltered nuclear fraction. In
the presence of MgCl2 (MgCl2), an essential cofactor of
FADS (13, 24), FAD synthesis was found to occur at a rate of
0.014 Amin1, corresponding to 15 pmol of newly synthe-
sized FADmin1mg1 protein. A value of 18.1 
 4.8
pmolmin1mg1 protein was measured in two different
nuclear preparations, in good agreement with the HPLC
analysis.
Evidence for a FADHydrolyzing Capacity of Rat Liver Nuclei—
Thus, both the HPLC and the enzymatic assays performed
demonstrated a robust nuclear FAD synthesis, suggesting, as
previously described for NAD (46), a role for nuclear FADS in
the biogenesis of the nuclear flavoproteins, among which there
are lysine-specific demethylases (27).
In this perspective, we reasoned that one of the mechanisms
potentially involved in the regulation of the nuclear flavin
cofactor pool could have been the existence of a dynamic equi-
librium between synthesis and hydrolysis of FAD. Thus, a last
series of experiments aimed at assessingwhether or not isolated
nuclei can hydrolyze exogenously added FAD was performed.
Upon FAD (5 M) addition to purified nuclei, flavin fluores-
cence emission spectra (excitation wavelength, 450 nm) were
recorded for up to 250 min at different time intervals in the
500–600 nm wavelength range. Fluorescence emission at 520
nm (Fig. 7A), the wavelength at which all the flavins show their
emission maximum, linearly increased with time for up to 100
min (Fig. 7A, inset). Because FMN and Rf fluorescence con-
stants are10-fold higher than that of FAD (see “Experimental
FIGURE 6. Chromatographic and enzymatic evidence of nuclear FAD synthesis. A, upper panel, typical HPLC chromatogram of neutralized perchloric acid
extracts of isolatednuclei from rat liver showing flavin content (see “Experimental Procedures”). Lower panel, time course of FAD synthesis catalyzedby rat liver
nuclei added to 2M FMN, 5mMATP, and 5mMMgCl2 in 50mM Tris-Cl (pH 7.5) at 37 °C, in the absence (F) or in the presence (E) of 50MHgCl2. B, the amount
of FAD in ultrafiltered rat liver nuclei was enzymatically assayed by using the FAD detecting system (FADS D.S.), here schematized and described in greater
detail under “Experimental Procedures.” Ultrafiltered nuclei (0.06 mg of protein) were incubated at 37 °C for 5 min in 100 l of 50 mM Tris-HCl (pH 7.5) in the
absence (dotted line,FMN & ATP) or in the presence of the substrate pair 2M FMN and 1mM ATP (straight lines). The effect of 5 mMMgCl2 on FAD synthesis
was also evaluated.
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Procedures”), the results reported in Fig. 7A strongly suggested
that FAD to FMN/Rf conversion could have taken place. By
measuring the rate of fluorescence increase at 520 nm in differ-
ent nuclear preparations, a mean rate of 1.15 
 0.14 nmol of
FAD hydrolyzedmin1mg1 protein was found. No increase
in fluorescence intensity at 520 nm was measured when 5 mM
EDTA was added (Fig. 7A, inset).
To further confirm FAD hydrolyzing activity in rat nuclei,
FMN/Rf formation from FAD was assayed by HPLC with a
similar experimental approach. Thus, exogenously added FAD
was incubated with isolated nuclei either in the absence or in
the presence of EDTA, and neutralized perchloric extracts of
the reaction mixtures at different time intervals were analyzed
by HPLC. As clearly shown by the typical chromatogram
reported in the upper panel of Fig. 7B, the addition of FAD
caused the appearance of newly formed FMN and Rf, whose
amounts were found to increase over time, with a simultaneous
decrease in FAD levels (chromatograms a–c). The rate of FAD
to FMN hydrolysis was comparable with that measured by the
fluorimetric assay (1.4 nmolmin1mg1 of protein), whereas
the rate of Rf formation was slower (0.15 nmolmin1mg1 of
protein). No FMN or Rf formation was found to occur in the
suspension previously added with EDTA (chromatograms
a–c).
These results show that nuclei can metabolize externally
added FAD to give FMN, via a putative FAD pyrophosphatase,
and more slowly Rf, via monoester hydrolases that are still not
characterized. The kinetic behavior of the reaction and the cor-
respondence between the two methods used to detect FAD
hydrolysis demonstrate that the fluorimetric approach used
here (more rapid and less expensive than the classical HPLC
approaches) is a suitable model for the characterization of
nuclear FAD pyrophosphatase.
FAD hydrolysis was then characterized with respect to the
following features: dependence on substrate concentration
(data not shown), sensitivity toward inhibitors, and pH profile
(Fig. 7C).Hyperbolic characteristicswere foundwith saturation
kinetics as analyzed by the Michaelis and Menten equation.
Thus, a Km equal to 0.44 
 0.03 M and a Vmax equal to 1.3
nmolmin1mg1 of protein for FAD were calculated.
As far as the inhibition of FAD hydrolysis is concerned, a
significant result of this part of the study is the inhibition found
by purine nucleotides. In particular, ATP-induced inhibition of
the process was found to be stronger than that obtained with
FIGURE 7. FAD hydrolysis by isolated rat liver nuclei. A, rat liver nuclei (0.1 mg of protein) were incubated for 1 min as described under “Experimental
Procedures,” and then 5M FADwas added. Flavin fluorescence emission spectra weremonitored at different incubation times. In the inset, the fluorescence
measured at 520 nm, as obtained either in the absence (F) or presence (E) of 5 mM EDTA, was plotted against time. B, chromatographic evidence of FAD
hydrolysis catalyzed by pure nuclei. FAD, FMN, and Rf were revealed by HPLC in nuclear extracts obtained after 0 min (chromatograms a and a), 4 min
(chromatograms b and b), and 120 min (chromatograms c and c) of incubation with FAD, either in the absence (chromatograms a–c) or in the presence
(chromatograms a–c) of 5 mM EDTA. C, some features of FAD hydrolysis are reported. The rate of FAD hydrolysis by pure nuclei (0.4 mg of proteins) was
measured fluorimetrically. In chromatograma, the pHprofile of the rate of FAD (5M) hydrolysis is shown. 100mMacetate/acetic acid and 50mMTris-HCl (with
5 mM MgCl2) at different pH values were used as buffering mixtures. A specific calibration curve was obtained at each pH value as described under “Experi-
mental Procedures.” Thevalues are reportedaspercentagesof themaximumrate (6.3nmolmin1mg1 ofprotein) arbitrarily set equal to100%. The inhibition
by externally added GTP, ATP, and AMP (chromatogram b) or NADH and NAD (chromatogram c) on the rate of FAD (0.6 M) hydrolysis is shown. The data
shown in chromatograms b and cwere fitted according to a single exponential decay equation using the Grafit software (version 3.00; Erithacus Software).
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GTP (being IC50 equal to 1.7 and 5.5 M, respectively; see Fig.
7C). Interestingly, AMP (IC50 equal to 0.7 M) and adenylate
containing pyridine nucleotides, such as NADH and NAD,
powerfully inhibited FADhydrolysis, with IC50 values of 0.6 and
3 M, respectively. Among inorganic compounds, NaF was
found to reduce by 50% the FAD hydrolysis reaction rate at 1
mM; at higher concentrations, NaF strongly inhibited the reac-
tion. No inhibition was found by tartrate (used at concentra-
tions up to 1 mM), a powerful inhibitor of the lysosomal acid
phosphatase (48).
Concerning the pH profile, the rate of FAD hydrolysis was
found to be quite slow in the pH range 4–7 and very fast at
alkaline pH, with a maximum value at pH 9 (Fig. 7C). The
marked inhibition exerted by the reduced nicotinamide nucle-
otide, by other dinucleotides (i.e., CoA and P1,P5-di-adeno-
sine-5-pentaphosphate), and by the inorganic compoundNaF,
together with the optimal activity registered at alkaline pH,
strongly suggests that the hydrolyzing activitymeasured in pure
nuclei could be due to one of the already characterized NUDIX
hydrolases, prominent among the enzymes responsible for
metabolizing nucleotides (49).
DISCUSSION
This paper deals with the role played by flavin cofactor
metabolism and its compartmentalization in different subcel-
lular domains. In opposition to pyridine nucleotide cofactors,
whose metabolism has been extensively investigated in the last
decades (50–52), the crucial function of flavin cofactors in cell
biology has been quite neglected.
A piece of work in this direction has been made in our labo-
ratory that has focused the research activity on the study of
FAD biosynthesis and its subcellular localization in different
organisms, including mammals (see Ref. 8 and references
therein). Overcoming the assumption of an exclusive cytosolic
localization for the enzymes responsible for FAD synthesis sus-
tained by many laboratories (13, 14, 16, 17), we first proposed a
mitochondrial localization for FADS both in rat liver and in
mammalian cell lines (BHK-21 and Caco-2) transiently
expressing hFADS1 (18, 19, 23, 53).
In this paper, we demonstrate for the first time a novel sub-
cellular localization for this enzyme in different experimental
rat models. In particular, we prove here the presence of FADS
protein in the nuclei of primary cells and cell lines by classical
immuno-based techniques and its functionality in intact nuclei
from rat liver by biochemical assays.
The first direct demonstration of different FADS localization
was obtained by confocal immunofluorescence experiments.
The images reported in Fig. 2 clearly indicate that in cells in
which the oxidative metabolism is expected to be crucial, i.e.,
neonatal rat ventricular cardiomyocytes, FADS localizes not
only in the cytosol but also in mitochondria and nuclei, as
already suspected when observing the corresponding immuno-
fluorescence results obtained on BHK-21 fibroblasts (see non-
transfected cells in Fig. 6 of Ref. 23 and Fig. 1 of this paper). The
nuclear localization of FADSwas further confirmed in different
rat primary cultures (cardiac fibroblasts and astrocytes) and cell
lines (insulin secreting  cells, INS1-E) subjected to the same
immunofluorescence analysis (Figs. 3 and 4).
The presence of FADS and the enrichment of its activity in
nuclei were further confirmed at the functional level in pure
nuclei isolated by rat liver homogenate using both HPLC and
spectrophotometric assays (Fig. 6). Pure rat liver nuclei, free
from any trace of both cytosolic and mitochondrial marker
enzymes (Fig. 5A), were shown to synthesize FAD with a spe-
cific activity equal to 18.1 pmolmin1mg1 protein, corre-
sponding to a total FADS activity of 0.2 nmol FADmin1.
Because nuclear proteins represent 4% of the total proteins
present in the homogenate, these results indicate that this
enzyme contributes to the total activity of FAD synthesis less
than cytosol and mitochondria (18).
As regards the flavin nuclear content, pure rat liver nuclei
were shown to contain 3-fold less total flavin cofactors in
respect to mitochondria (18). This observation tallies with the
presence of a large number of flavoenzymes in mitochondria
and with the subsequent high FAD autofluorescence measured
in this subcellular compartment in living cells (54). Together
with the evaluation of a significant presence of FAD tightly
bound to proteins, the biochemical assay performed here
allowedus to characterize in somedetail the nuclear FAD form-
ing enzyme, revealing its strict Mg2 dependence and sensitiv-
ity to mercurial reagents, in agreement with what has already
been observed for hFADS2 (38, 47).
Regarding the anti-FADS immunoreactive bands revealed in
immunoblotting experiments on pure nuclei, although their
specificity has been definitely demonstrated by immunoinhibi-
tion experiments, their classification as alternative splicing
variants, post-translationally modified isoforms or degradation
products, is still under investigation. In humans, at least four
alternative splicing products of the FLAD1 gene have been
demonstrated to be concurrently expressed in different cell
lines/tissues (8). The corresponding products differ from each
other at either theN- orC-terminal region, with the longest one
being isoform 1, localized in mitochondria (8, 23). A FADS
migrating on SDS-PAGE with a molecular mass of 65 kDa was
also identified in human neurons (26). Different from humans,
only a single transcript corresponding to a predicted product of
490 amino acids (54.6 kDa) is at the moment reported for
rats in Ensembl (accession number ENSRNOP00000028030)
and NCBI Entrez gene (gene identifier 751787.) databases.
UniprotKB (Uniprot no. B1WBY2) reported an additional tran-
script corresponding to a predicted product of 474 amino acids
(52.6 kDa). However, a wide BLAST search in nonredundant
protein sequence database using as a query the human FADS
isoforms 1 and 2 gave two additional products of 552 amino
acids (61.5 kDa) and 371 amino acids (40.7 kDa), annotated in
the GenBankTM database (accession numbers EDM00631.1
and EDM00632.1), both performing a 90% identity with the
humanproteins. The four putative rat isoforms differ fromeach
other at the C-terminal region, and the 474-amino acid protein
lacks 17 residues (corresponding to the 324–340 amino acid
region). Unfortunately, a clear subcellular localization predic-
tion using common bioinformatics analyses was possible for
none of these proteins (23, 24). Thus, we can postulate that in
rats, as in humans, a dynamic control by alternative splicing
could regulate the expression/localization of specific FADS
isoforms.
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Also, it can be hypothesized that one of these isoforms may
migrate to the nucleus in response to chemicophysical changes
because of post-translational modifications induced, for exam-
ple, by different metabolic states of the cell. Using the different
post-translational modification prediction programs, available
on the ExPASy tool, for all the rat isoforms a phosphorylation
site at position 70 by protein kinase Cwas predicted with a high
probability (score equal to 0.72). Also the CSS-Palm 3.0 soft-
ware (55) set with the default threshold predicts two palmitoy-
lation sites at positions 39 and 312 (with scores of 0.33 and 1.74,
respectively) and an additional site at position 547 (with a score
of 3.20) for the 552-amino acid isoform. Interestingly, this
palmitoylation site is adjacent to a transmembrane helices pre-
dicted with high probability by the TMpred software. Other
post-translational modifications were not predicted (i.e.,
O-glycosylations) or predicted with a low probability (i.e.,
sumoylation, using both the SUMOplotTM analysis program
and Sumosp 2.0 software (56)). Tissue distribution and subcel-
lular localization of these isoforms are still uncharacterized (8,
26) and represent one of the ongoing research efforts in our
laboratory.Whatever the isoformdetails, to our knowledge this
is the first evidence that FAD synthesis occurs in the nucleus,
andwe postulate that, as hypothesized by others (27), this event
could be linked to the biogenesis and flavinylation of nuclear
flavoproteome (Fig. 8).
In addition, our results indicate for the first time the exist-
ence of FAD hydrolyzing enzymes in the nucleus. The kinetic
features of the FAD hydrolytic activity as characterized in pure
rat liver nuclei suggest that it could be due to one of the already
characterized NUDIX hydrolases. In humans, at least 24 genes
and 5 pseudogenes encoding NUDIX hydrolases exist, and
most of their protein products have been characterized to some
extent. In rats, the corresponding orthologues exist (see the
UniprotKB database), all of them inferred by homology.
Although there is evidence at the transcript level for some of
them, data at the protein level have been collected, and specific
studies have been performed on just three of them: NUDT1
(57), NUDT6 (58), and NUDT3 (59). The members of this
FIGURE 8. FAD homeostasis inmammalian cells. FAD cofactor is represented in this drawing by a star. Flavin transporters are indicated with circles (circled I,
plasma membrane Rf transporter, i.e., RFVT1–3 described in Ref. 12; circled II, mitochondrial Rf transporter, still uncharacterized; circled III, mitochondrial FAD
exporter). The question mark indicates the unknown origin of Rf in the nucleus. FAD-synthesizing enzymes are indicated with gray boxes (box 1, riboflavin
kinase; box 2, FADS). FAD degrading enzymes are indicated withwhite boxes (box 3, FAD pyrophosphatase; box 4, FMN phosphohydrolase). Apo-flavoprotein
(apo-Fp) into holoflavoprotein (holo-Fp) transition and FAD recycling are indicatedwithdotted lines. Somenuclear flavoenzymes are indicatedwithwhite boxes
with a star. AIF, apoptosis inducing factor1; LSD1/2, lysine-specific demethylase 1/2; TXNRD1, thioredoxin reductase. The scheme summarizes the functional
studies described in this and other previous papers (18, 61, 62).
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superfamily show diverse substrate specificity as well as differ-
ent subcellular localizations (cytoplasm, nucleus, mitochon-
dria, peroxisomes, plasma membrane) (60). A NUDIX hydro-
lase that efficiently hydrolyzes FAD has been characterized in
mammals, namely NUDT12 (49), but its localization appears to
be peroxisomal. Whether and how the same enzyme could be
responsible for FAD hydrolysis in the nucleus remain to be
established. Quite interesting is the ability of adenylate-con-
taining nucleotides to inhibit nuclear FAD hydrolysis. In par-
ticular, the ability of the nuclear FAD hydrolyzing enzyme to
discriminate between the redox states of pyridine nucleotides
might suggest a novel role for nuclear NAD(H) redox status in
regulating nuclear FAD homeostasis.
The results described in this paper, together with the intrigu-
ing, albeit still speculative, hypothesis that riboflavin kinase
exists in rat liver nuclei, allow us to propose the occurrence of a
Rf/FAD cycle in the nucleus, as previously suggested for mito-
chondria (18) (Fig. 8). Nuclear FADS could thus concur, together
with cytosolic andmitochondrial FADS, to the creationof a “flavin
network,” a scenario that is strictly in linewith the recent literature
demonstrating a fundamental role for cellular FADbiosynthesis in
regulating cellular energy balance (27).
Comprehension of how and when the cell regulates flavin
homeostasis, as well as the precise understanding of the physi-
ological role exerted by FADbiosynthetic pathways in the three
different subcellular compartments, requires further investiga-
tion. Answering such questions appears to be of special interest
in light of the recent notion that impairment in flavoenzymes
activity and flavin supply/metabolism could have a role in the
pathogenesis ofRf-responsivemyopathies (see review inRef. 8 and
references therein) and of the emerging role of FAD and other
vitamin-derived cofactors as regulators of epigenetic events.
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